Arvinas Androgen Receptor Inc, based in New Haven, is a clinical-stage biotechnology company at the forefront of developing targeted protein degradation therapeutics.
The company is dedicated to advancing innovative treatments through its expertise in this cutting-edge approach to drug development.
Generated from their website's infomation